Ensign Peak Advisors’s BioXcel Therapeutics BTAI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-338
Closed -$64K 1846
2022
Q3
$64K Hold
338
﹤0.01% 2166
2022
Q2
$71K Hold
338
﹤0.01% 2024
2022
Q1
$113K Hold
338
﹤0.01% 2005
2021
Q4
$110K Buy
+338
New +$110K ﹤0.01% 2044